Emergent Biosolutions Inc

From Powerbase
Revision as of 15:22, 31 October 2013 by Matthew Pringle (talk | contribs) (basic page created)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Background

Emergent BioSolutions (NYSE: EBS) is a multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. It develops vaccines and therapeutics for infectious diseases, oncology and autoimmune disorders.

People

  • Michael Milligan - Secretary General
  • Thomas Barmüller - Director EMEA
  • Aderbal Bonturi Pereira - Latin America Director
  • Sabine Lobnig - Communications & Regulatory Officer

Affiliations

Contact

Corporate
2273 Research Boulevard
Suite 400
Rockville, MD 20850
USA
Tel: 301-795-1800
Fax: 301-795-1899

Notes